ArticleBMC chemistry2025
Determination of bioactive profile of Polygala vulgaris L. by GC-MS and molecular docking.
Article in BMC chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Plants, being immobile, are constantly exposed to various biotic and abiotic stresses, leading to the generation of reactive oxygen species (ROS) which disrupt cellular homeostasis and cause oxidative damage. To combat this, plants have evolved various enzymatic and non-enzymatic antioxidant mechanisms. This study investigates the enzymatic activities of key antioxidants in Polygala vulgaris L., a species within the Polygalaceae known for its medicinal properties. The enzymatic activities of), catalase (CAT), superoxide dismutase (SOD), manganese superoxide dismutase (MnSOD) and phenol oxidase (PO) were measured. Additionally, the content of malondialdehyde (MDA), a marker for oxidative stress, was determined. The methanol extract of P. vulgaris L. was analyzed using GC-MS to identify bioactive compounds, and molecular docking studies were conducted to assess the interactions and binding energies of these compounds with the lysosomal integral membrane protein-2 (LIMP 2). LIMP 2 interaction of the extract suggested that it may trigger Parkison's disease and at the same time protect the organism from enterovirus invasion. Results indicated significant antioxidant activity in P. vulgaris L., with potential implications for its use in mitigating oxidative stress-related cellular damage. The study provides a comprehensive overview of the antioxidant defense mechanisms in P. vulgaris L. and underscores its potential for future pharmacological applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.